EPOTHILONDERIVATE

Patent europeic · EP1546152 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP1546152
Numer da la dumonda
EP03747872
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
01-08-2003
Publitgà
29-06-2005
Concedì
19-12-2007
Stritgà
31-08-2009
Motiv
Taxa annuala betg pajada
Classas IPC
C07D 493/04 (2006.01)
C07D 417/06 (2006.01)
C07D 405/06 (2006.01)
C07D 407/06 (2006.01)
A61K 31/427 (2006.01)
A61K 31/4427 (2006.01)
A61P 35/00 (2006.01)
A61P 17/06 (2006.01)
Prioritad
US 400535 P 02.08.2002
US 480933 P 24.06.2003
Dumonda PCT
PCT/EP2003/008554 01.08.2003
Publicaziun PCT
WO2004/014919 19.02.2004
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 17-03-2010

    Stritgà, taxa betg pajada

    Published in Swissreg on 17.03.2010

  2. 29-02-2008

    Represchentant inscrit

    Representative
    Novartis AG, Lichtstrasse 35, 4056 Basel

    Published in +pat+ No 4 in 2008

  3. 15-01-2008

    Concedì

    Published in +pat+ No 1 in 2008

Partidas

Inventur

NAMOTO, Kenji

8006 Zürich

NICOLAOU, Kyriacos, Costa

La Jolla, CA 92037, US

RITZEN, Andreas

DK-2720 Vanlose, DK

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.